People Will Become More Accepting Of Jabs: Expert
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576240_1_20210218165956.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-02-18 HKT 17:16
Dr Leung Chi-chiu speaks to Wendy Wong
A specialist in respiratory medicine said on Thursday that he believed more people would be willing to receive coronavirus vaccine once the inoculation programme is rolled out, although various surveys suggested a low acceptance rate.
Previous polls showed only between 30 and 40 per cent of Hong Kong people would get the jabs, but Dr Leung Chi-chiu said he believed their attitude would change over time.
He said he expected the public to become less worried about the vaccine’s safety as more people get inoculated.
“For something new, I think the initial acceptance may be low. That should not be a major issue because the priority groups account for about 2.4 million people. And we only have sufficient vaccine in the initial stage for one million,” he said.
“If we can roll out the programme successfully, I’m certain that the attitude will change with time. As time goes, there will be further data not only from abroad but also from the local application. That should relieve the anxiety of people who might be worried about the vaccine’s safety profile.”
He noted that an expert panel appointed by the government has yet to decide on whether the vaccine produced by mainland drug maker Sinovac can be given to elderly people aged over 60.
He said the decision would affect how quickly protection could be offered to elderly people living in care homes here.
“This is crucial because this vaccine does not require the super cold storage syringe. They can be more easily handled by the outreach teams. If they can be applied for the elderly, they can be quickly utilised to cover our old age homes,” he said.
Ant International And Bank Of China Partner To Enhance Cross-Border Payment Connectivity
Ant International and Bank of China (Hong Kong) (“BOCHK”) announced a partnership which leverages BOCHK’s banking... Read more
BitGo Korea Gets Green Light For Virtual Asset Custody, Backed By SK Telecom
BitGo Holdings, Inc. (BitGo) announced that its subsidiary, BitGo Korea, Inc. (BitGo Korea), received its Virtual Asset... Read more
Webinar: When Account Takeover Moves Past Onboarding
Account takeover shows why fraud risk cannot be treated as an onboarding problem. Fraudsters are using stolen credentia... Read more
JCB To Trial Stablecoin Payments In Japan With Digital Garage And Lawson
JCB Co., Ltd. (JCB), Digital Garage, Inc. (Digital Garage), and Lawson, Inc. (Lawson) announced that they have jointly ... Read more
Bonnie Chan To Lead HKEX Until Feb 2030 After Securing Second Term
The HKEX Board of Directors has approved the renewal of the employment contract of Hong Kong Exchanges and Clearing Lim... Read more
Ripple Signs Its First Korean Regional Bank In Cross-Border Remittance Deal
Ripple, a blockchain-based enterprise solutions provider for traditional and digital finance, announced a partnership w... Read more
